Medlab Middle East 2024 Provides a Peek into the Laboratory of the Future
By LabMedica International staff writers Posted on 05 Feb 2024 |

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets, has returned to the Dubai World Trade Centre. Now in its 23rd year, Medlab Middle East features 900 exhibitors from more than 40 countries, up 20% from last year, and is being attended by more than 30,000 attendees. As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in developing the value of laboratory medicine in reshaping the future of diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers, and distributors, to share best practice, showcase innovations, collaborate and network.
Medlab Middle East 2024 is exhibiting eight specialized product categories which include disposables, healthcare/general services, imaging, infrastructure, IT, laboratory, medical equipment and pharma/nutrition. Attendees can explore the latest laboratory technologies from every corner of the globe with dedicated country pavilions from China, Taiwan, Brazil, Finland, Poland, the USA, Spain, Korea, Italy, Egypt, and the UK. A key highlight of the 2024 edition of Medlab Middle East, taking place from 5-8 February, is the newly introduced ‘NextGen Medicine Zone and Conference, which is hosted in partnership with Express Med Diagnostics and Research (Manama, Bahrain). This innovative exhibition zone showcases over 100 exhibitors and brings into focus a pioneering area in the medical laboratory field that aims to customize healthcare to individuals, using advanced technologies and new developments in medical science.
The NextGen Medicine Conference, taking place from 5 to 6 February, explores topics such as early cancer detection, precision oncology, preventative health screening, longevity, developments in cancer genetics and oncogenomics as well as updates on Middle East genome projects. The conference also explores the digitalization aspects of NextGen Medicine which includes Artificial Intelligence (AI), bioinformatics, and the cybersecurity of data. Attendees can stay up to date with the latest insights and innovations in NextGen Medicine at expert-led industry workshops running from 5-7 February. Medlab Middle East Congress, the region’s only multi-disciplinary congress, has returned for another year. Offering 12 CME-accredited live in-person conferences throughout the four-day exhibition, the congress features over 130 speakers and 150 sessions, with over 4,000 delegates expected. NextGen Medicine and Clinical Genomic Interpretation are new additions to the Medlab Middle East congress this year, with returning tracks including Laboratory Management, Lab Quality Management, Clinical Chemistry, Immunology, Hematology, Clinical Microbiology, Blood Transfusion Medicine, Histopathology, Future of Lab and Sustainability in the Lab.
Additionally, innovation takes center stage at Labpreneur, Medlab Middle East’s annual start-up competition. Held on the last day of the exhibition, Labpreneur features 10 shortlisted start-ups that have created revolutionary concepts for the medical laboratory field. The winner of the competition is set to receive complimentary stand space for Medlab Middle East 2025 along with a prestigious award. Fostering the talents of future scientists, Medlab Middle East is hosting the second edition of LabQ, an inter-college quiz competition on pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. The Scientific Poster Competition is returning this year, with the winner receiving a research grant of a value of up to USD 3,000. Elsewhere, attendees can expand their knowledge of the medical laboratory industry at the Medlab Partners Forum, which includes a think tank session from global research firm Frost & Sullivan and an insightful presentation from The Royal College of Pathologists on ‘The Global Challenge of Antimicrobial Resistance’.
“Medlab Middle East provides a unique platform for the laboratory industry to showcase innovative products, state-of-the-art services, and cutting-edge solutions in a central global hub,” said Tom Coleman, Exhibition Director for Informa Markets. “One of the most exciting features of this year's exhibition is the NextGen Medicine Zone and Conference, which promises to be a game-changer in the field. This groundbreaking zone will bring together experts from around the world who will share the latest scientific advancements, providing a unique opportunity for industry professionals to learn and explore new possibilities.”
Related Links:
Informa Markets
Express Med Diagnostics and Research
Latest Medlab 2024 News
- Anbio Biotechnology Presents Point-Of-Care IVD Solutions
- 77 Elektronika Showcases Latest Developments in Urinalysis
- BioVendor Group Unveils Latest Innovations in Immunodiagnostics and Molecular Diagnostics
- Sansure Presents Future of Pathogen Identification and Disease Diagnosis
- Spinreact Presents Latest Developments in IVD
- Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings
- YHLO Unveils New iBC 900 Automated Chemistry Analyzer
- Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics
- Dymind Introduces New High-End Hematology Analyzer with Innovative Functions
- DIRUI Exhibits Latest Lab Automation Technologies and Devices
- Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer
- Boule Presents Next Generation Hematology and Clinical Chemistry Systems
- bioMérieux Showcases Advanced Generation of VIDAS Immunoassay Solution
- BioPerfectus Highlights Diagnostic Solutions for HPV & Cervical Cancer Screening, STIs and Vector-Borne Diseases
- Mindray Showcases Range of Advanced Total IVD Solutions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more